Viridian Therapeutics, Inc. (VRDN)
23.01
+0.58
(+2.59%)
USD |
NASDAQ |
Oct 21, 16:00
23.14
+0.13
(+0.56%)
After-Hours: 20:00
Viridian Therapeutics Net Income (Annual) : -281.93M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -281.93M |
| December 31, 2024 | -208.56M |
| December 31, 2023 | -237.73M |
| December 31, 2022 | -129.87M |
| December 31, 2021 | -79.41M |
| December 31, 2020 | -110.72M |
| December 31, 2019 | -41.87M |
| Date | Value |
|---|---|
| December 31, 2018 | -32.70M |
| December 31, 2017 | -26.52M |
| December 31, 2016 | -17.32M |
| December 31, 2015 | -11.33M |
| December 31, 2014 | -7.89M |
| December 31, 2013 | -2.160M |
| December 31, 2012 | -5.618M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Vertex Pharmaceuticals, Inc. | 3.953B |
| TG Therapeutics, Inc. | 447.18M |
| Travere Therapeutics, Inc. | -50.26M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |